Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Guidelines for evaluation and management of cognitive disorders in HIV-positive individuals

Underwood, Jonathan ORCID: https://orcid.org/0000-0001-6963-2821 and Winston, Alan 2016. Guidelines for evaluation and management of cognitive disorders in HIV-positive individuals. Current HIV/AIDS Reports 13 (5) , 235--240. 10.1007/s11904-016-0324-x

[thumbnail of 82444880.pdf] PDF - Published Version
Download (127kB)

Abstract

Antiretroviral therapy has revolutionised the treatment for people living with HIV (PLWH). Where antiretroviral coverage is high, the treatment paradigm for HIV-disease is now one of managing the long-term consequences of the virus and its treatment rather than the consequences of untreated HIV-disease such as immunosuppression and opportunistic infections. One such long-term consequence is HIV-associated cognitive impairment which is reported to occur in up to 50 % of treated PLWH and has been associated with poorer outcomes. Given the ageing cohort and increased frequency of comorbidities, the prevalence of symptomatic cognitive impairment may increase with time. High quality evidence for management strategies including screening, diagnosis and treatment of HIV-associated cognitive impairment are lacking and in general guidelines are based on best clinical practice. In this article, we assessed recent guidelines concerning the management of HIV-associated cognitive impairment by performing a systematic review of the MEDLINE database using PubMed. We report that, in general, guidelines from around the world regarding the management of HIV-associated cognitive impairment are converging. Screening is generally not recommended in asymptomatic PLWH. Diagnosis of HIV-associated cognitive impairment should be made only after a comprehensive assessment and exclusion of other potential causes. Antiretroviral therapy forms the cornerstone of management of HIV-associated cognitive impairment and should be guided by plasma and cerebrospinal fluid (CSF) genotype(s).

Item Type: Article
Date Type: Published Online
Status: Published
Schools: Medicine
Additional Information: This article is published with open access at Springerlink.com
Publisher: Current Medicine Group
ISSN: 1548-3568
Date of First Compliant Deposit: 15 August 2019
Last Modified: 05 May 2023 07:27
URI: https://orca.cardiff.ac.uk/id/eprint/124858

Citation Data

Cited 25 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics